Nature Features Portal Instruments in BioPharma Dealmakers’ Quarterly Magazine
June 5, 2017
Portal Instruments was recently re-featured in Nature’s BioPharma Dealmakers’ quarterly magazine, ahead of the BIO International 2017 event to be held in San Diego, CA over June 19-22, 2017.
Portal Instruments Marks Milestone, Publishing Results of Study in Peer-Reviewed Article in AAPS PharmSciTech
May 16, 2017
The clinical trial involving 40 healthy volunteers demonstrated that the reported pain associated with an injection using the Portal system was significantly lower than that reported from a subcutaneous injection with a 27G needle.
Portal Instruments Receives IS0 13485:2012 Certification
April 24, 2017
This certificate of registration from an independent organization ensures that Portal’s Quality Management System has been assessed and deemed to comply with the requirements of the IS0 13485:2012 standard within the scope of the following operations – namely the design, manufacture and distribution of hand-held needle-free injection devices for drug administration.
Portal Technology Featured on BBC
March 18, 2017
Portal was recognized by the BBC as a promising innovation at the SXSW Interactive Innovation Awards Finalist showcase in Austin, Texas.
Portal Instruments attends Injectable Drug Delivery Conference in London
March 17, 2017
The Injectable Drug Delivery Conference focuses on the evolution of injection devices over time, from simple mechanical devices to connected and holistic drug delivery mechanisms that improve usability, safety, efficacy and compliance.
Portal Instruments Wins SXSW Interactive Innovation Award in the Health, Med & Biotech Category
March 16, 2017
Known for celebrating the most inspiring, creative advancements of the year, the SXSW Interactive Innovation Award recognized Portal’s needle-free drug delivery platform as “the new technology that best improves the quality, efficacy, and cost-effectiveness of prevention, diagnosis, treatment and care in health and medicine.”
Patrick Anquteil to Feature in New Innovations in Drug Delivery Technology Webcast
March 9, 2017
This webcast will highlight a range of diverse technologies and explain their applications in diseases such as oncology, CNS diseases and women’s health.
Portal Instruments Closes Second Tranche of $25 Million Series B Financing
March 9, 2017
Portal Instruments had received an initial investment of $10 million in October 2015 as part of this Series B financing. Portal announced today that it had closed the additional $15 million following the achievement of certain development milestones.
Portal Instruments Present at 2017 DDP Conference
February 3, 2017
DDP is the world’s largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies.
Portal Instruments selected as Finalist in SXSW Interactive Innovation Awards
February 3, 2017
The Advisory Board of SXSW Interactive Innovation Awards has selected Portal Instruments to be a finalist in its Health, Med & Biotech category. "This recognition from a diverse and innovative community is a privilege and confirms our conviction that we are (re)moving the needle on an important unmet need for patients with chronic disease,” says Patrick Anquetil, CEO of Portal Instruments.